Tasly Pharmaceutical Group Co Ltd - Company Profile
Powered by 
All the data and insights you need on Tasly Pharmaceutical Group Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Tasly Pharmaceutical Group Co Ltd Strategy Report
- Understand Tasly Pharmaceutical Group Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Tasly Pharmaceutical Group Co Ltd (Tasly) manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The company's product line includes herbal medicine, chemical medicine, prescription drugs, pharmaceutical substances, health product, active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series, and medical equipment. It markets products in the domestic market through its own sales force and through distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, the Netherlands, and the US. Tasly is headquartered in Tianjin, China.
Headquarters
China
Address
Tasly Modern Tcm Building, No. 2, Pujihe East Road, Beichen District, Tianjin, 300410
Website
www.taslypharma.com
Telephone
86 22 26736999
No of Employees
9,183
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600535 (SHA)
Revenue (2021)
$1.3B
8.1%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
-110.9%
(2021 vs 2020)
Market Cap*
$3.1B
Net Profit Margin (2021)
XYZ
-110.1%
(2021 vs 2020)
* As of and is in US$
Tasly Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Herbal Medicines |
| Chemical Medicines |
| Modern Chinese Medicines |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In October, the company and Huawei Cloud Computing Technology Co entered into a cooperation agreement to integrate traditional Chinese medicine characteristic data and the basic capabilities of the Pangu large model. |
| 2022 | Official Trials/Tests | In August, Lianxia Xiaopi Granules completed a randomized, double-blind, placebo-controlled, randomized, double-blind, placebo-controlled, clinical trial of the efficacy and safety of the treatment of functional dyspepsia. |
| 2022 | Contracts/Agreements | In July, the company formed a joint venture with Mauna Kea Technologies of Paris for China commercialization of Mauna Kea’s Cellvizio, a needle-based confocal laser endomicroscopy platform. |
Competitor Comparison
| Key Parameters | Tasly Pharmaceutical Group Co Ltd | Sinopharm Group Co Ltd | Shanghai Pharmaceuticals Holding Co Ltd | China National Accord Medicines Corporation Ltd | China Resources Sanjiu Medical & Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Tianjin | Shanghai | Shanghai | Shenzhen | Shenzhen |
| State/Province | Tianjin | Shanghai | Shanghai | Guangdong | Guangdong |
| No. of Employees | 9,183 | 115,959 | 48,164 | 39,296 | 20,318 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yan Kaijing | Chairman | Executive Board | 2015 | 44 |
| Su Jing | Director; General Manager | Executive Board | - | 60 |
| Jie Wei | Director - Finance | Senior Management | 2018 | 46 |
| Jie Yu | Secretary; Vice President | Senior Management | 2018 | 48 |
| Xiaomeng Jiang | Vice Chairman | Non Executive Board | 2008 | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward